Unknown

Dataset Information

0

Warfarin dose requirement in patients having severe thrombosis or thrombophilia.


ABSTRACT: AIMS:Warfarin dose requirement varies significantly. We compared the clinically established doses based on international normalized ratio (INR) among patients with severe thrombosis and/or thrombophilia with estimates from genetic dosing algorithms. METHODS:Fifty patients with severe thrombosis and/or thrombophilia requiring permanent anticoagulation, referred to the Helsinki University Hospital Coagulation Center, were screened for thrombophilias and genotyped for CYP2C9*2 (c.430C>T, rs1799853), CYP2C9*3 (c.1075A>C, rs1057910) and VKORC1 c.-1639G>A (rs9923231) variants. The warfarin maintenance doses (target INR 2.0-3.0 in 94%, 2.5-3.5 in 6%) were estimated by the Gage and the International Warfarin Pharmacogenetics Consortium (IWPC) algorithms. The individual warfarin maintenance dose was tailored, supplementing estimates with comprehensive clinical evaluation and INR data. RESULTS:Mean patient age was 47 years (range 20-76), and BMI 27 (SD 6), 68% being women. Forty-six (92%) had previous venous or arterial thrombosis, and 26 (52%) had a thrombophilia, with 22% having concurrent aspirin. A total of 40% carried the CYP2C9*2 or *3 allele and 54% carried the VKORC1-1639A allele. The daily mean maintenance dose of warfarin estimated by the Gage algorithm was 5.4 mg (95% CI 4.9-5.9 mg), and by the IWPC algorithm was 5.2 mg (95% CI 4.7-5.7 mg). The daily warfarin maintenance dose after clinical visits and follow-up was higher than the estimates, mean 6.9 mg (95% CI 5.6-8.2 mg, P < 0.006), with highest dose in patients having multiple thrombophilic factors (P < 0.03). CONCLUSIONS:In severe thrombosis and/or thrombophilia, variation in thrombin generation and pharmacodynamics influences warfarin response. Pharmacogenetic dosing algorithms seem to underestimate dose requirement.

SUBMITTER: Helin TA 

PROVIDER: S-EPMC6624394 | biostudies-literature | 2019 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Warfarin dose requirement in patients having severe thrombosis or thrombophilia.

Helin Tuukka A TA   Joutsi-Korhonen Lotta L   Asmundela Heidi H   Niemi Mikko M   Orpana Arto A   Lassila Riitta R  

British journal of clinical pharmacology 20190617 8


<h4>Aims</h4>Warfarin dose requirement varies significantly. We compared the clinically established doses based on international normalized ratio (INR) among patients with severe thrombosis and/or thrombophilia with estimates from genetic dosing algorithms.<h4>Methods</h4>Fifty patients with severe thrombosis and/or thrombophilia requiring permanent anticoagulation, referred to the Helsinki University Hospital Coagulation Center, were screened for thrombophilias and genotyped for CYP2C9*2 (c.430  ...[more]

Similar Datasets

| S-EPMC4735233 | biostudies-literature
| S-EPMC3461592 | biostudies-literature
| S-EPMC4453805 | biostudies-literature
| S-EPMC6724157 | biostudies-literature
2022-02-23 | GSE181439 | GEO
| S-EPMC5960187 | biostudies-literature
| S-EPMC5093054 | biostudies-literature
| S-EPMC2515137 | biostudies-literature
| S-EPMC6714673 | biostudies-literature
| S-EPMC7851666 | biostudies-literature